Abstract
OBJECTIVES:: Relatively little is known about rates of outpatient adverse drug events (ADEs), and most health systems do not routinely identify them. We developed a computerized ADE measurement process and used it to detect ADEs from electronic health records and then categorized them according to type, preventability, and severity. METHODS:: The rules used represent combinations of variables including coded medication names, laboratory results, diagnoses, and specific items such as symptoms from free text clinician notes, all obtained from electronic health records. Rules targeted various diagnostic and laboratory abnormalities potentially caused by a broad range of outpatient medications commonly used in primary care. The rules were run on 4 months of data on primary care patients seen in the outpatient setting in 2 large health systems; possible incidents were identified by chart review and validated as ADEs by clinician reviewers, then rated by severity and preventability. RESULTS:: The rates of ADEs were 75 ADEs/1000 person-years and 198/1000 person-years at the 2 sites, respectively. The overall rate was 138 ADEs/1000 person-years across the 2 sites. Eleven percent of ADEs were preventable, with a rate of 15 preventable ADEs/1000 person-years across sites. Approximately one-fourth of ADEs were serious or life threatening at both sites. The highest yield rules for identifying preventable ADEs included rules based on drug classes and symptoms, and drug-laboratory rules. CONCLUSIONS:: Adverse drug events occurred frequently in routine outpatient care, and many were serious and preventable. Computerized monitoring represents an efficacious approach for identifying ambulatory ADEs, although it needs additional refinement. In addition, site-specific variations need further exploration.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 91-96 |
| Number of pages | 6 |
| Journal | Journal of Patient Safety |
| Volume | 6 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jun 1 2010 |
Fingerprint
Keywords
- Adverse drug event
- Ambulatory care
- Computerized adverse drug event monitor
- Natural language processing
- Patient safety
ASJC Scopus subject areas
- Leadership and Management
- Public Health, Environmental and Occupational Health
Cite this
Outpatient adverse drug events identified by screening electronic health records. / Gandhi, Tejal K.; Seger, Andrew C.; Overhage, J. Marc; Murray, Michael D.; Hope, Carol; Fiskio, Julie; Teal, Evgenia; Bates, David W.
In: Journal of Patient Safety, Vol. 6, No. 2, 01.06.2010, p. 91-96.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Outpatient adverse drug events identified by screening electronic health records
AU - Gandhi, Tejal K.
AU - Seger, Andrew C.
AU - Overhage, J. Marc
AU - Murray, Michael D.
AU - Hope, Carol
AU - Fiskio, Julie
AU - Teal, Evgenia
AU - Bates, David W.
PY - 2010/6/1
Y1 - 2010/6/1
N2 - OBJECTIVES:: Relatively little is known about rates of outpatient adverse drug events (ADEs), and most health systems do not routinely identify them. We developed a computerized ADE measurement process and used it to detect ADEs from electronic health records and then categorized them according to type, preventability, and severity. METHODS:: The rules used represent combinations of variables including coded medication names, laboratory results, diagnoses, and specific items such as symptoms from free text clinician notes, all obtained from electronic health records. Rules targeted various diagnostic and laboratory abnormalities potentially caused by a broad range of outpatient medications commonly used in primary care. The rules were run on 4 months of data on primary care patients seen in the outpatient setting in 2 large health systems; possible incidents were identified by chart review and validated as ADEs by clinician reviewers, then rated by severity and preventability. RESULTS:: The rates of ADEs were 75 ADEs/1000 person-years and 198/1000 person-years at the 2 sites, respectively. The overall rate was 138 ADEs/1000 person-years across the 2 sites. Eleven percent of ADEs were preventable, with a rate of 15 preventable ADEs/1000 person-years across sites. Approximately one-fourth of ADEs were serious or life threatening at both sites. The highest yield rules for identifying preventable ADEs included rules based on drug classes and symptoms, and drug-laboratory rules. CONCLUSIONS:: Adverse drug events occurred frequently in routine outpatient care, and many were serious and preventable. Computerized monitoring represents an efficacious approach for identifying ambulatory ADEs, although it needs additional refinement. In addition, site-specific variations need further exploration.
AB - OBJECTIVES:: Relatively little is known about rates of outpatient adverse drug events (ADEs), and most health systems do not routinely identify them. We developed a computerized ADE measurement process and used it to detect ADEs from electronic health records and then categorized them according to type, preventability, and severity. METHODS:: The rules used represent combinations of variables including coded medication names, laboratory results, diagnoses, and specific items such as symptoms from free text clinician notes, all obtained from electronic health records. Rules targeted various diagnostic and laboratory abnormalities potentially caused by a broad range of outpatient medications commonly used in primary care. The rules were run on 4 months of data on primary care patients seen in the outpatient setting in 2 large health systems; possible incidents were identified by chart review and validated as ADEs by clinician reviewers, then rated by severity and preventability. RESULTS:: The rates of ADEs were 75 ADEs/1000 person-years and 198/1000 person-years at the 2 sites, respectively. The overall rate was 138 ADEs/1000 person-years across the 2 sites. Eleven percent of ADEs were preventable, with a rate of 15 preventable ADEs/1000 person-years across sites. Approximately one-fourth of ADEs were serious or life threatening at both sites. The highest yield rules for identifying preventable ADEs included rules based on drug classes and symptoms, and drug-laboratory rules. CONCLUSIONS:: Adverse drug events occurred frequently in routine outpatient care, and many were serious and preventable. Computerized monitoring represents an efficacious approach for identifying ambulatory ADEs, although it needs additional refinement. In addition, site-specific variations need further exploration.
KW - Adverse drug event
KW - Ambulatory care
KW - Computerized adverse drug event monitor
KW - Natural language processing
KW - Patient safety
UR - http://www.scopus.com/inward/record.url?scp=77953175437&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953175437&partnerID=8YFLogxK
U2 - 10.1097/PTS.0b013e3181dcae06
DO - 10.1097/PTS.0b013e3181dcae06
M3 - Article
C2 - 22130350
AN - SCOPUS:77953175437
VL - 6
SP - 91
EP - 96
JO - Journal of Patient Safety
JF - Journal of Patient Safety
SN - 1549-8417
IS - 2
ER -